Siegfried Michel
Director/Board Member at Vifor Pharma UK Ltd.
Profile
Siegfried Michel currently works at Vifor Pharma UK Ltd., as Director from 2018 and Vifor Fresenius Medical Care Renal Pharma UK Ltd., as Director from 2018.
Siegfried Michel active positions
Companies | Position | Start |
---|---|---|
Vifor Pharma UK Ltd.
Vifor Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., Vifor Pharma UK Ltd. is a company that researches, develops, and manufactures pharmaceutical products. The company is based in Bagshot, UK and was founded in 2010. | Director/Board Member | 2018-04-23 |
Vifor Fresenius Medical Care Renal Pharma UK Ltd.
Vifor Fresenius Medical Care Renal Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Vifor Fresenius Medical Care Renal Pharma UK Ltd. is a pharmaceutical company that engages in research, development, and manufacturing of pharmaceutical products for the treatment of iron deficiency. The company is based in London, UK and is a part of Vifor Fresenius Medical Care Renal Pharma Ltd. | Director/Board Member | 2018-06-13 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Vifor Pharma UK Ltd.
Vifor Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., Vifor Pharma UK Ltd. is a company that researches, develops, and manufactures pharmaceutical products. The company is based in Bagshot, UK and was founded in 2010. | Health Technology |
Vifor Fresenius Medical Care Renal Pharma UK Ltd.
Vifor Fresenius Medical Care Renal Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2015, Vifor Fresenius Medical Care Renal Pharma UK Ltd. is a pharmaceutical company that engages in research, development, and manufacturing of pharmaceutical products for the treatment of iron deficiency. The company is based in London, UK and is a part of Vifor Fresenius Medical Care Renal Pharma Ltd. | Health Technology |
- Stock Market
- Insiders
- Siegfried Michel